Physician profile
Chester C Lee
NPI 1912177890
$1,561.55
in general payments reported to CMS, 2019-2025
15 companies · $170 in 2025
The $170 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $478 · 2020: $68.70 · 2021: $132 · 2022: $404 · 2023: $98.03 · 2024: $211 · 2025: $170.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $480.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $479.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $314.94 | 2024-2025 | Aquabeam System |
| Boston Scientific Corporation | $304.03 | 2019-2022 | |
| Abbvie INC. | $226.09 | 2021-2022 | |
| Astellas Pharma US INC | $225.68 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $124.99 | 2019 | |
| Pfizer INC. | $90.49 | 2019-2024 | |
| Abbott Laboratories | $81.49 | 2023 | Diamondback Coronary |
| Urovant Sciences INC | $46.70 | 2022 | |
| Myovant Sciences INC. | $37.67 | 2021-2022 | |
| Sanara Medtech INC. | $24.00 | 2024 | Celleraterx |
| Olympus America INC. | $21.02 | 2025 | Itind System |
| Dendreon Pharmaceuticals LLC | $20.02 | 2020 | |
| Sumitomo Pharma America, INC. | $16.54 | 2023 | Gemtesa |
| Teleflex LLC | $15.82 | 2022 | |
| Ferring Pharmaceuticals INC. | $12.07 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chester Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.